HORAN Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Buy
884
+60
+7% +$61.3K 0.13% 96
2026
Q1
$758K Buy
824
+15
+2% +$15.2K 0.07% 117
2025
Q4
$869K Buy
809
+9
+1% +$8.61K 0.13% 88
2025
Q3
$610K Hold
800
0.1% 121
2025
Q2
$624K Buy
+800
New +$622K 0.19% 70

Other funds holding LLY

HORAN Wealth's LLY Position: Q2 2026 in Review

HORAN Wealth increased its Eli Lilly (LLY) stake by 7.3% in Q2 2026, buying an estimated $61.3K and bringing the position to 884 shares worth $1.06M. The position accounts for 0.13% of the portfolio, ranked #96.

HORAN Wealth first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • HORAN Wealth held 884 shares of Eli Lilly worth $1.06M as of Q2 2026.
  • HORAN Wealth bought 60 Eli Lilly shares in Q2 2026, an estimated $61.3K.
  • Eli Lilly made up 0.13% of HORAN Wealth's portfolio in Q2 2026, its #96 holding.
  • HORAN Wealth first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on HORAN Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.